Clinical trial
Study of Adjuvant Radiochemotherapy for Gastric Cancer
NCT00188266 · University Health Network, Toronto, Other · Completed
Key facts
| NCT number | NCT00188266 |
|---|---|
| Title | Study of Adjuvant Radiochemotherapy for Gastric Cancer |
| Official title | Prospective Phase I/II Study of Adjuvant Radiochemotherapy for Gastric Cancer |
| Lead sponsor | University Health Network, Toronto, Other |
| Collaborators | Princess Margaret Hospital, Canada |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Stomach Neoplasms |
| Intervention type | Drug |
| Interventions | cisplatinum combined with infusional fluorouracil (5 FU) |
| Enrollment | 65 |
| Start date | Aug 1, 2002 |
| Primary completion | Dec 19, 2013 |
| Completion | Aug 18, 2017 |
| First posted | Sep 16, 2005 |
| Last update posted | Sep 20, 2017 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: